Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Lehner

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Nature Communications|March 2, 2026
Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editingBasheer Becerra, Sandra Wittibschlager, Zain M Patel, et al.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Science Advances|September 4, 2024
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activationVanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas, et al.
Cancer Immunology Research|December 6, 2024
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell LeukemiaMichelle C Buri, Mohamed R Shoeb, Aleksandr Bykov, et al.
Science Immunology|October 17, 2025
Protein palmitoylation and sphingolipid metabolism control regulated exocytosis in cytotoxic lymphocytesArtem Kalinichenko, Jakob Huemer, Theresa Humer, et al.
Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Nature Communications|March 2, 2026
Nucleotide-resolution mapping of regulatory elements via allelic readout of tiled base editingBasheer Becerra, Sandra Wittibschlager, Zain M Patel, et al.
Frontiers in Immunology|January 26, 2023
The frequency of differentiated CD3<sup>+</sup>CD27<sup>-</sup>CD28<sup>-</sup> T cells predicts response to CART cell therapy in diffuse large B-cell lymphomaNina Worel, Katharina Grabmeier-Pfistershammer, Bernhard Kratzer, et al.
Science Advances|September 4, 2024
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activationVanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas, et al.
Cancer Immunology Research|December 6, 2024
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell LeukemiaMichelle C Buri, Mohamed R Shoeb, Aleksandr Bykov, et al.
Science Immunology|October 17, 2025
Protein palmitoylation and sphingolipid metabolism control regulated exocytosis in cytotoxic lymphocytesArtem Kalinichenko, Jakob Huemer, Theresa Humer, et al.
Cancer Cell|December 31, 2021
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicitySabine Heitzeneder, Kristopher R Bosse, Zhongyu Zhu, et al.
Pageof 4